These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 867013)
1. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency]. Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013 [TBL] [Abstract][Full Text] [Related]
2. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Mimran A; Shaldon S; Barjon P; Mion C Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368 [TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate]. Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176 [TBL] [Abstract][Full Text] [Related]
4. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin. Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855 [TBL] [Abstract][Full Text] [Related]
5. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension. Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167 [TBL] [Abstract][Full Text] [Related]
7. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension]. Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696 [TBL] [Abstract][Full Text] [Related]
9. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)]. Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II blockade in congestive heart failure. Turini GA; Brunner HR; Ferguson RK; Rivier JL; Gavras H Arch Int Pharmacodyn Ther; 1978 May; 233(1):166-76. PubMed ID: 686905 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension. Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897 [TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
13. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects]. Beyer J; Liebau G; Steiner B; Schick K; Hayduk K Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577 [No Abstract] [Full Text] [Related]
14. The use of saralasin in the recognition of angiotensinogenic hypertension. Streeten DH; Dalakos TG; Anderson GH Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165 [TBL] [Abstract][Full Text] [Related]
15. Immediate hemodynamic response to SQ 14225 (Captopril) in hypertensive and normotensive hemodialysis patients. Iseki K; Onoyama K; Fujimi S; Omae T Clin Nephrol; 1981 Sep; 16(3):137-41. PubMed ID: 7028334 [TBL] [Abstract][Full Text] [Related]
16. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166 [TBL] [Abstract][Full Text] [Related]
17. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)]. Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404 [No Abstract] [Full Text] [Related]
18. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man. Arlart IP; Rosenthal J; Wagner H; Franz HE Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic correlates of saralasin: responsiveness in hypertension. Kem DC; Frohlich ED; de Carvalho JG; Dunn FG; Chrysant SG; Danisa K; Wambach G Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866 [No Abstract] [Full Text] [Related]
20. Hemodynamic correlates of saralasin-induced arterial pressure changes. de Carvalho JG; Dunn FG; Kem DC; Chrysant SG; Froholich ED Circulation; 1978 Feb; 57(2):373-8. PubMed ID: 618629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]